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Depression and beta-thalassemia:
a genetic link?
To the Editor:
Beta-thalassemia is one of the most preva-
lent monogenic illnesses in the world. It is
causedbymutations in the beta chainof the
hemoglobin molecule. Genetic studies sug-
gest an important genetic factor in the
etiology of depressive disorders. Several
candidate genes, most notably the gene
situated on chromosome 11, proximal to
the genes involved in beta-thalassemia, are
potentially involved in the development of
depressive disorders in predisposed indi-
viduals (1). In reporting a case in which
recurrent depression and thalassemia
minor (heterozygous beta-thalassemia)
occurred simultaneously in several mem-
bers of a family, one can suggest the
existenceofagenetic linkbetween these two
disorders. The patient gave her consent for
this report to be published.
Ms A, a 38-year-old Caucasian woman,
native fromBelgium, had an 8-year history
of recurrent major depressive disorder
without psychotic symptoms (DSM-IV).
She was hospitalized three times for
depressive episodes. The patient had
a family history of recurrent major
depression involving two generations
(father and two paternal uncles). A mild
anemia was diagnosed during her first
hospitalization at the age of 30 as thalas-
semia minor following DNA analysis. The
four family members (including the
patient) and her son aged 15 had thalasse-
mia minor. They all fulfilled the Research
Diagnosis Criteria for recurrent major
depression except her son who was in good
mental health. Other family members had
no psychiatric or somatic diseases.
Depression in Ms A is unlikely to be
attributable to psychosocial consequences
of thalassemia minor as the disease had
little clinical effect on her and other
members of her family.
Depression is the most frequent psychi-
atric disorder in the community, and its
lifetime prevalence inmen andwomen is 13
and 21%, respectively (2). Several linkage
studies suggest that genetic components
may contribute to the development of
depressive disorders (1). However, the
identification of these genetic factors en-
counters several obstacles: the complex
interactions between physiological, psy-
chological andenvironmental elements; the
clinical heterogeneity of depressive disor-
ders; and the presence of phenocopies (3).
Several studies reveal, however, that by
the sequencing of chromosome 11, a possi-
ble genetic susceptibility for depression can
be located on the short arm of this
chromosome near the gene involved in
beta-thalassemia (11p15). In fact, one of
the human tryptophan hydroxylase genes
(TPH1), the rate-limiting enzyme in sero-
tonin biosynthesis, is implicated in depres-
sive disorders andcanbe foundon the short
arm of chromosome 11 (11p14-p15.3) (4).
No study has yet been done to examine
the prevalence of beta-thalassemia in
patients with depressive disorders, but an
estimate based on the prevalence of each
disorder (13–21% depression and ,1%
beta-thalassemia northern European
populations) suggests that the possibility
of observing both disorders in multiple
individuals in two families is rare, thus
providing tentative support for a possible
genetic link between the two disorders.
A review of literature revealed no reports
of possible genetic relationship between
thalassemia minor and depressive disor-
ders. To our knowledge, our case study is
the first report that discusses a possible
association between these two disorders.
In conclusion, genetic studies have
described the existence of a genetic suscep-
tibility factor for depressivedisorders on the
short arm of chromosome 11, near to the
gene involved in beta-thalassemia.We have
described a case report so as to highlight
a possible genetic link between these two
pathologies.A known genetic disease (beta-
thalassemia) can help to confirm the
presence, on the short arm of chromosome
11, of a genetic susceptibility factor for
depression. Linkage studies should be
performed in families with a strong associ-
ation of both diseases in order to improve
our understanding of the physiopathology
of depressive disorders, along with possible
therapeutic implications.
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